Urokinase plasminogen activator surface receptor Inhibitors (IC50, Ki)

Structure ▲ ▼	Compound Name ▲ ▼	Standard Type ▲ ▼	Standard Values (in nM) ▲ ▼
	3-Aminoquinoxalin-2(1H)-one	Ki	20.8 [1]
	2-[[12-(3,5-Dimethylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid	IC50	10000.0 [1]
	6,12-Dihydroquinoxalino[2,3-b][1,4]benzodiazepin-13-one	Ki	1.33 [1]
	2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43R,49S)-25-(4-Aminobutyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-[3-(diaminomethylideneamino)propyl]-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecazapentacyclo[29.20.4.07,11.013,17.043,47]pentapentacontan-40-yl]acetic acid	Ki	500000.0 [1]
	3-(1H-Benzimidazol-2-yl)-1-(1H-benzimidazol-2-ylmethyl)-5-phenylpyrrol-2-amine	Ki	0.0 [1]
	6-(1H-Benzimidazol-2-ylmethyl)-11H-quinoxalino[2,3-b][1,4]benzodiazepin-13-one	Ki	0.01 [1]
	2-Amino-1-(1H-benzimidazol-2-ylmethyl)-5-phenyl-pyrrole-3-carbonitrile	Ki	0.0 [1]
	3-(1H-Benzimidazol-2-yl)-5-phenyl-1-(2-pyridyl)pyrrol-2-amine	Ki	0.01 [1]
	3-(1H-Benzimidazol-2-yl)-1-(3-chlorophenyl)-5-phenylpyrrol-2-amine	Ki	0.0 [1]
	6-[(1-Prop-2-enylbenzimidazol-2-yl)methyl]-11H-quinoxalino[2,3-b][1,4]benzodiazepin-13-one	Ki	0.0 [1]
	2-Amino-1-(1H-benzimidazol-2-yl)-5-phenyl-pyrrole-3-carbonitrile	Ki	0.0 [1]
	3-(1H-Benzimidazol-2-yl)-5-phenyl-1-(4-pyridyl)pyrrol-2-amine	Ki	0.0 [1]
	3-(1H-Benzimidazol-2-yl)-1-(4-bromophenyl)-5-phenyl-pyrrol-2-amine	Ki	0.01 [1]
	Ethyl 2-[2-[(13-oxo-11H-quinoxalino[2,3-b][1,4]benzodiazepin-6-yl)methyl]benzimidazol-1-yl]acetate	Ki	0.0 [1]
	3-(1H-Benzimidazol-2-yl)-1-(3-bromophenyl)-5-phenyl-pyrrol-2-amine	Ki	0.01 [1]
	1,3-Bis(1H-benzimidazol-2-yl)-5-phenyl-pyrrol-2-amine	Ki	0.0 [1]
	3-(1H-Benzimidazol-2-yl)-1-(4-chlorophenyl)-5-phenylpyrrol-2-amine	Ki	0.0 [1]
	2-Amino-1-(4-chlorophenyl)-5-phenylpyrrole-3-carbonitrile	Ki	0.0 [1]
	2-Amino-1-(3-chlorophenyl)-5-phenylpyrrole-3-carbonitrile	Ki	0.0 [1]
	2-Amino-1-(4-bromophenyl)-5-phenylpyrrole-3-carbonitrile	Ki	0.0 [1]
	3-[[12-(3-Ethoxycarbonylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]propanoic acid	IC50	51000.0 [1]
	4-[[12-(3-Methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]butanoic acid	IC50	20000.0 [1]
	4-[[12-(3,5-Dimethylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]butanoic acid	IC50	36000.0 [1]
	3-[[12-(3-Methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]propanoic acid	IC50	24000.0 [1]
	2-[(8-Oxo-12-pyrrolidin-1-yl-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl)amino]benzoic acid	IC50	21000.0 [1]
	3-[[12-(3-Methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid	IC50	7000.0 [1]
	3-[[12-(2-Methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid	IC50	10000.0 [1]
	3-[[12-(3,5-Dimethylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid	IC50	5000.0 [1]
	(2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21S,26S,29R)-21-amino-3,18-bis(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid	IC50	30000.0 [1]
	(2S)-4-Amino-2-[[(3S,6R,9S,12R,15R,18R,21S,26S,29R)-21-amino-15-(4-aminobutyl)-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid	IC50	30000.0 [1]
	(2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18S,21S,26S,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid	IC50	30000.0 [1]
	(2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21S,26S,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid	IC50	900.0 [1]
	(3S,6R,9S,12R,15S,18R,21S,27S,32S,35R,38S,41R)-27-Amino-18,35-bis(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-21,38-bis(hydroxymethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,34,37,40-dodecaoxo-3-propan-2-yl-29,30-dithia-1,4,7,10,13,16,19,22,25,33,36,39-dodecazabicyclo[39.3.0]tetratetracontane-32-carboxylic acid	IC50	700.0 [1]
	(2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21R,26R,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(naphthalen-2-ylmethyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid	IC50	80.0 [1]
	(2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21R,26R,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(naphthalen-1-ylmethyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid	IC50	50.0 [1]
	(2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21R,26R,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-butyl-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid	IC50	60.0 [1]
	(3S,6R,9S,12R,15S,18R,21S,27R,32S,35R,38S,41R)-27-Amino-18,35-bis(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-21,38-bis(hydroxymethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,34,37,40-dodecaoxo-3-propan-2-yl-29,30-dithia-1,4,7,10,13,16,19,22,25,33,36,39-dodecazabicyclo[39.3.0]tetratetracontane-32-carboxylic acid	IC50	200.0 [1]
	(2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21R,26R,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid	IC50	40.0 [1]
	(2S)-4-Amino-2-[[(3S,6S,9S,12R,15S,18R,21S,26S,29R)-21-amino-18-(2-amino-2-oxoethyl)-15-(2-carboxyethyl)-6-(hydroxymethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid	IC50	30000.0 [1]
	3-[[12-(3,5-Dimethylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]propanoic acid	IC50	18000.0 [1]
	4-[[8-Oxo-12-(4-oxopiperidin-1-yl)-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid	IC50	100000.0 [1]
	4-[[[3-(1,3-Benzodioxol-5-yl)-4-phenylbutyl]amino]methyl]-N,N-dimethylaniline	Ki	20000.0 [1]
	2-Phenacylpropanedinitrile	Ki	0.3 [1]
	Methyl 3-[[12-(azepan-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoate	IC50	100000.0 [1]
	3-[(3-Bromo-4-hydroxy-6,7-dimethyl-9,10-dioxoanthracen-1-yl)amino]benzoic acid	IC50	67000.0 [1]
	2-Amino-5-phenyl-1-pyridin-4-ylpyrrole-3-carbonitrile	Ki	0.01 [1]
	3-[(3-Bromo-9,10-dioxo-4-propan-2-yloxyanthracen-1-yl)amino]benzoic acid	IC50	30000.0 [1]
	3-[(3-Bromo-4-hydroxy-6-methyl-9,10-dioxoanthracen-1-yl)amino]benzoic acid	IC50	146000.0 [1]
	2-Amino-5-phenyl-1-pyridin-2-ylpyrrole-3-carbonitrile	Ki	0.03 [1]
	3-[(3-Bromo-9,10-dioxo-4-phenylmethoxyanthracen-1-yl)amino]benzoic acid	IC50	30000.0 [1]
	4-[[12-(3-Methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]methyl]benzoic acid	IC50	11000.0 [1]
	2-Amino-1-(3-bromophenyl)-5-phenylpyrrole-3-carbonitrile	Ki	0.0 [1]
	2-[[12-[(3S,5S)-3,5-Dimethylpiperidin-1-yl]-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid	IC50	10000.0 [1]

Entire TableStructureCompound NameStandard TypeStandard Values (in nM)

Items per page: 510All1 - 10 of 53 ⟨⟩

---

---

References

This online tool may be cited as follows

MLA	"Quest Database™ Urokinase plasminogen activator surface receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 9 May. 2024, https://www.aatbio.com/data-sets/urokinase-plasminogen-activator-surface-receptor-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2024, May 9). Quest Database™ Urokinase plasminogen activator surface receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/urokinase-plasminogen-activator-surface-receptor-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan